# Gabapentin Treatment of Cannabis Dependence

> **NCT00974376** · PHASE2 · COMPLETED · sponsor: **The Scripps Research Institute** · enrollment: 150 (actual)

## Conditions studied

- Cannabis Dependence
- Cannabis Withdrawal
- Cognitive Deficits

## Interventions

- **DRUG:** gabapentin 1200mg/day
- **DRUG:** Placebo
- **BEHAVIORAL:** Manual-guided behavioral counseling

## Key facts

- **NCT ID:** NCT00974376
- **Lead sponsor:** The Scripps Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-04
- **Primary completion:** 2016-05-19
- **Final completion:** 2016-05-19
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974376, "Gabapentin Treatment of Cannabis Dependence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00974376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*